ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

GSK Gsk Plc

1,335.00
0.00 (0.00%)
02 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1,335.00 1,333.50 1,334.00 - 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1889 11.22 55.34B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,335p. Over the last year, Gsk shares have traded in a share price range of 1,282.50p to 1,820.00p.

Gsk currently has 4,145,087,815 shares in issue. The market capitalisation of Gsk is £55.34 billion. Gsk has a price to earnings ratio (PE ratio) of 11.22.

Gsk Share Discussion Threads

Showing 29501 to 29525 of 34075 messages
Chat Pages: Latest  1183  1182  1181  1180  1179  1178  1177  1176  1175  1174  1173  1172  Older
DateSubjectAuthorDiscuss
07/2/2022
13:00
IN 2543 shares @ 1630.80
tradermichael
07/2/2022
12:32
Good point - the new techniques will add competition.
alphorn
07/2/2022
12:29
Alp,

one of the main concerns I have on the GSK pharma business is recent progress
made by other companies on vaccine development. GSK may find their vaccine
franchise facing significantly more competition on several fronts over
the medium term?.

Whether valid, you might have a better handle on.

The flipside is rump pharma arguably an easier takeover target.

essentialinvestor
07/2/2022
12:25
GlaxoSmithKline plc will announce its full year and fourth quarter 2021 results to the London Stock Exchange at 07:00 GMT on Wednesday 9 February 2022.

Analysts and investors are invited to participate in a conference call and webcast, including a presentation of the results and a Q&A session. This event will take place on the same day at 14:00 GMT.

To participate, please join the live audio webcast, which can be accessed directly via the website . The presentation will also be available on the website about one hour before the event's start.

tradermichael
07/2/2022
12:09
Re. my earlier post on marking time - any damage to the pipeline will not show for some time (years). IMO this fuffing around over the group's future has been poorly handled. Sad to see, what was the UK's largest market cap, the group disappearing as it gets broken up.
alphorn
07/2/2022
12:04
All depends on the company performance to be covered in the results on Wednesday.
tradermichael
07/2/2022
12:01
No, spoole5, you should know by now that the drop (if any) on xd day is only temporary and often the price recovers some before close and in the following days!
tradermichael
07/2/2022
12:00
Its not ex-dividend until 17 February!
tradermichael
07/2/2022
11:58
It's already ex dividend.
southwinds
07/2/2022
11:57
That should push it sub 16!
spoole5
07/2/2022
09:17
xd 23p per share next week .... ;0)
tradermichael
07/2/2022
08:17
Dead money here until the split
spoole5
06/2/2022
14:18
TM




yep my latest hope for lots of things

THE SUM OF THE PARTS IS WORTH MORE THAN THE WHOLE

waldron
06/2/2022
13:56
Marking time, correct. Early 2001 the share price topped 2000p. 21 years of no overall capital gain (though plenty of swings en route to make money by trading, propped up with lots of dividends). Here's relying on the 'split' to unlock capital from the 'sum-of-the-parts'!
tradermichael
06/2/2022
13:08
The damage to the business in the interim could be huge as personnel consider their futures. I could imagine that the business is marking time.
alphorn
06/2/2022
12:59
Not much different to the teenage scribblers of old. The demerger needs hurrying up. No doubt it's complicated but it seems to be taking an inordinate amount of time bearing in mind these managers are being paid millions of pounds a year.
patientcapital
06/2/2022
12:41
Glaxo are only handing out £1.15bn (23p a share) as they have already paid out nearly £3bn in the first three quarters of this year.
Not very good with detail these 'so called' financial reporters!

jonjoneil
06/2/2022
00:56
GlaxoSmithKline and Unilever set to hand out combined £8bn in dividends, after
suffering blistering attacks from US activist investors

philanderer
05/2/2022
15:26
Broken up the pieces become more digestible.
alphorn
05/2/2022
15:18
The takeover is out of the question as it is too big to purchase and it would certainly go through Monopoly Commission. The Govt don't want a repeat of ARM saga.
maxplus2
03/2/2022
22:13
I assume we will get more info about the timetable for the split in the results next week.
gateside
03/2/2022
16:05
Not likely it's too close to GSK splitting time .
abdullla
03/2/2022
14:57
Do they? Looks like retesting 1500s to me
spoole5
03/2/2022
07:29
Indeed, technicals looking very promising. All it needs is a couple of wins from Mr Barron’s drug delivery programme and it should be moving north at pace. Elliott will be pleased
daneswooddynamo
03/2/2022
02:12
To all the moaners, remoaners and doubters can I refer you to the share price graph since March 2021. Way to go the Dame. More to come I suspect.
pcok
Chat Pages: Latest  1183  1182  1181  1180  1179  1178  1177  1176  1175  1174  1173  1172  Older

Your Recent History

Delayed Upgrade Clock